Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000029·IONIS PHARMACEUTICALS INC
Schedule 13G ownership disclosure
IONIS PHARMACEUTICALS INC
Common Stock · CUSIP: 462222100
Event date: 2024-12-31
- Filing-level shares
- 16,472,539
- Percent of class
- 10.43%
- The Vanguard Group
Shares: 16,472,539 · Class: 10.43%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000029
- Form type
- SCHEDULE 13G/A
- Filer
- IONIS PHARMACEUTICALS INC
- CIK
- CIK 874015
- Filed
- Jan 08, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership